Geneva, June 20 -- International Clinical Trials Registry received information related to the study (ACTRN12625000620426) titled 'A Phase 1, First-In-human PET imaging study to assess [68Ga]Ga-AB101 in participants with Advanced Solid Tumours' on June 13.
Study Type: Interventional
Study Design:
Purpose: Diagnosis
Allocation: Non-randomised trial
Masking: Open (masking not used)
Primary Sponsor: ARTBIO Inc
Condition:
Advanced solid tumours
Advanced solid tumours
Cancer - Breast
Cancer - Lung - Non small cell
Cancer - Oesophageal (gullet)
Cancer - Head and neck
Intervention:
This is an open-label, non-controlled, interventional Phase 1 clinical study of a gallium-68 (68Ga) labelled PET imaging tracer in patients with solid tumours ...